Literature DB >> 10733018

Factors that may predispose to rupture of tubal ectopic pregnancy.

D Roussos1, D Panidis, I Matalliotakis, G Mavromatidis, M Neonaki, M Mamopoulos, E Koumantakis.   

Abstract

OBJECTIVE: The purpose of our study was to evaluate factors that may predispose to rupture of tubal ectopic pregnancy. The study included 99 cases of ectopic pregnancies that were treated during the 5-year period 1992-1996.
RESULTS: It was found that: (1) tubal rupture is encountered more often in women with no history of ectopic pregnancy and in those who have full-term pregnancy, suggesting that ectopic pregnancy is less suspected in these women; (2) tubal rupture is encountered less often in lower age ectopic pregnancy; and (3) serum beta-hCG level does not predict tubal rupture.
CONCLUSIONS: Rupture of the tube is more often observed in women with a history of ectopic pregnancy and in women with full-term pregnancy. Such observations suggest that ectopic pregnancy is less suspect in these cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733018     DOI: 10.1016/s0301-2115(99)00188-8

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

1.  Predictive value of maternal serum β-hCG concentration in the ruptured tubal ectopic pregnancy.

Authors:  Roya Faraji Darkhaneh; Maryam Asgharnia; Nastaran Farahmand Porkar; Ali Akbar Alipoor
Journal:  Iran J Reprod Med       Date:  2015-02

2.  Risk factors and clinical characteristics associated with a ruptured ectopic pregnancy: A 19-year retrospective observational study.

Authors:  Pei-Chen Li; Wen-Yu Lin; Dah-Ching Ding
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

3.  Fertility outcome after treatment of unruptured ectopic pregnancy with two different methotrexate protocols.

Authors:  Afsar Tabatabaii Bafghi; Fatemah Zaretezerjani; Leila Sekhavat; Raziah Dehghani Firouzabadi; Zeynab Ramazankhani
Journal:  Int J Fertil Steril       Date:  2012-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.